- Home
- BWFG vs LXRX Comparison
BWFG vs LXRX Comparison
Compare BWFG & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- LXRX
- Stock Information
- Founded
- BWFG 2002
- LXRX 1995
- Country
- BWFG United States
- LXRX United States
- Employees
- BWFG N/A
- LXRX N/A
- Industry
- BWFG Major Banks
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- BWFG Finance
- LXRX Health Care
- Exchange
- BWFG Nasdaq
- LXRX Nasdaq
- Market Cap
- BWFG 256.5M
- LXRX 273.9M
- IPO Year
- BWFG N/A
- LXRX 2000
- Fundamental
- Price
- BWFG $30.05
- LXRX $0.69
- Analyst Decision
- BWFG Buy
- LXRX Buy
- Analyst Count
- BWFG 1
- LXRX 2
- Target Price
- BWFG $40.00
- LXRX $6.00
- AVG Volume (30 Days)
- BWFG 16.0K
- LXRX 5.0M
- Earning Date
- BWFG 01-22-2025
- LXRX 03-10-2025
- Dividend Yield
- BWFG 2.66%
- LXRX N/A
- EPS Growth
- BWFG N/A
- LXRX N/A
- EPS
- BWFG 1.94
- LXRX N/A
- Revenue
- BWFG $72,009,000.00
- LXRX $5,229,000.00
- Revenue This Year
- BWFG N/A
- LXRX $842.94
- Revenue Next Year
- BWFG $9.07
- LXRX $19.76
- P/E Ratio
- BWFG $15.46
- LXRX N/A
- Revenue Growth
- BWFG N/A
- LXRX 886.60
- 52 Week Low
- BWFG $22.47
- LXRX $0.62
- 52 Week High
- BWFG $35.25
- LXRX $3.73
- Technical
- Relative Strength Index (RSI)
- BWFG 47.42
- LXRX 40.93
- Support Level
- BWFG $27.44
- LXRX $0.70
- Resistance Level
- BWFG $30.50
- LXRX $0.75
- Average True Range (ATR)
- BWFG 0.82
- LXRX 0.08
- MACD
- BWFG 0.02
- LXRX -0.00
- Stochastic Oscillator
- BWFG 59.05
- LXRX 7.14
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses, and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.